Industry ranking
Score of 99.2/100 qualifies for PaymentCheck Certification
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 30 Jan 2026 | 1 | 99% | 1% | 0% | 2% |
| 01 Jan 2025 - 30 Jun 2025 | 30 Jul 2025 | 0 | 99% | 1% | 0% | 2% |
| 01 Jul 2024 - 31 Dec 2024 | 29 Jan 2025 | 12 | 88% | 10% | 2% | 3% |
| 01 Jan 2024 - 30 Jun 2024 | 29 Jul 2024 | 21 | 28% | 44% | 28% | 9% |
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 29 | 37% | 34% | 29% | 19% |
| 01 Jan 2023 - 30 Jun 2023 | 28 Jul 2023 | 78 | 1% | 16% | 83% | 9% |
| 01 Jul 2022 - 31 Dec 2022 | 30 Jan 2023 | 76 | 2% | 9% | 89% | 10% |
| 01 Jan 2022 - 30 Jun 2022 | 28 Jul 2022 | 78 | 4% | 24% | 72% | 11% |
| 01 Jul 2021 - 31 Dec 2021 | 27 Jan 2022 | 29 | 68% | 9% | 23% | 13% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 9 | 92% | 7% | 1% | 8% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 29 | 57% | 42% | 1% | 13% |
| 01 Jan 2020 - 30 Jun 2020 | 28 Jul 2020 | 32 | 44% | 34% | 22% | 9% |
| 01 Jul 2019 - 31 Dec 2019 | 29 Jan 2020 | 30 | 59% | 33% | 8% | 19% |
| 01 Jan 2019 - 30 Jun 2019 | 30 Jul 2019 | 120 | 5% | 11% | 84% | 24% |
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | 231 | 6% | 4% | 90% | 32% |
| 01 Jan 2018 - 30 Jun 2018 | 31 Jul 2018 | 103 | 12% | 10% | 78% | 33% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
The Company follows a standard payment terms of "30 days end of the following month, in which the invoice is received". For Intercompany Vendor's the standard terms are "180 days from the date of invoice". The maximum contractual payment period (in days) - The maximum contractual payment terms for Intercompany Vendors is "180 days from the date of Invoice", for Vendors other than Intercompany vendors, the maximum contractual term is "30 days end of the following month". There have been no changes to the company standard terms during the reporting period.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
Average pay days for external vendors is 39 Days (excluding intercompany vendors).
Maximum contractual payment period agreed
180
a) In case of any invoice disputes, the relevant department within the company availing the services is informed by email. The relevant department would then inform the vendor via email/phone of the nature of dispute and get it resolved. b) In case of disputes relating to services, the relevant department before approving the costs would inform the Vendor over an email. In case the invoice is considered to be correct, the same is internally approved and paid. c) For minor invoice errors, the Finance department may send an email directly to the relevant finance contact on Vendor side.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Mercury Pharmaceuticals Limited is registered under SIC code 21100, manufacture of basic pharmaceutical products. The company has traded under several previous names, including Checkeuro Limited, Goldshield Pharmaceuticals Ltd and Mercury Pharma Limited, before adopting its current name in 2012. It has been controlled by Mercury Pharma Group Limited since 2021 and is linked to the ADVANZ PHARMA group, having been included in that group's modern slavery statement. Public contract records show an NHS England framework agreement for branded medicines awarded in 2019 with a total value exceeding £1.3 billion across the framework. The company operates as part of a wider pharmaceutical group rather than as a standalone manufacturing site.
Generated from the company's website and Companies House records. Sources: find-and-update.company-information.service.gov.uk · companiesintheuk.co.uk